{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:48:25Z","timestamp":1792172905841,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.amjmed.2018.05.022","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T20:21:54Z","timestamp":1528834914000},"page":"1228-1233.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2267-4239","authenticated-orcid":false,"given":"Todd C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-159X","authenticated-orcid":false,"given":"Rodrigo B.","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Pilote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8533","key":"10.1016\/j.amjmed.2018.05.022_bib0001","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(87)90231-5","article-title":"Benefits and potential harm of lowering high blood pressure","volume":"1","author":"Cruickshank","year":"1987","journal-title":"Lancet."},{"issue":"5","key":"10.1016\/j.amjmed.2018.05.022_bib0002","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/HYPERTENSIONAHA.111.178178","article-title":"Isolated diastolic hypotension and incident heart failure in older adults","volume":"58","author":"Guichard","year":"2011","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.amjmed.2018.05.022_bib0003","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2009.05.073","article-title":"The J-curve between blood pressure and coronary artery disease or essential hypertension","volume":"54","author":"Messerli","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjmed.2018.05.022_bib0004","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/HYPERTENSIONAHA.107.089797","article-title":"Diastolic blood pressure and mortality in the elderly with cardiovascular disease","volume":"50","author":"Protogerou","year":"2007","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.amjmed.2018.05.022_bib0005","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-144-12-200606200-00005","article-title":"Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?","volume":"144","author":"Messerli","year":"2006","journal-title":"Ann Intern Med."},{"issue":"17","key":"10.1016\/j.amjmed.2018.05.022_bib0006","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1001\/archinte.159.17.2004","article-title":"The role of diastolic blood pressure when treating isolated systolic hypertension","volume":"159","author":"Somes","year":"1999","journal-title":"Arch Intern Med."},{"issue":"4-5","key":"10.1016\/j.amjmed.2018.05.022_bib0007","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000175818","article-title":"Clinical importance of coronary perfusion pressure in the hypertensive patient with left ventricular hypertrophy","volume":"81","author":"Cruickshank","year":"1992","journal-title":"Cardiology"},{"issue":"16","key":"10.1016\/j.amjmed.2018.05.022_bib0008","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.jacc.2016.08.007","article-title":"Troponin and the J-curve of diastolic blood pressure: when lower is not better","volume":"68","author":"Bhatt","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.amjmed.2018.05.022_bib0009","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.jacc.2016.07.754","article-title":"Diastolic blood pressure, subclinical myocardial damage, and cardiac events: implications for blood pressure control","volume":"68","author":"McEvoy","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.amjmed.2018.05.022_bib0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/A:1007804030510","article-title":"Antihypertensive treatment: does the J-curve exist?","volume":"14","author":"Hansson","year":"2000","journal-title":"Cardiovasc Drugs Ther."},{"issue":"6","key":"10.1016\/j.amjmed.2018.05.022_bib0011","doi-asserted-by":"crossref","first-page":"438","DOI":"10.7326\/0003-4819-136-6-200203190-00007","article-title":"J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data","volume":"136","author":"Boutitie","year":"2002","journal-title":"Ann Intern Med."},{"issue":"9118","key":"10.1016\/j.amjmed.2018.05.022_bib0012","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.amjmed.2018.05.022_bib0013","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1007856014581","article-title":"Antihypertensive treatment and the J-curve","volume":"14","author":"Cruickshank","year":"2000","journal-title":"Cardiovasc Drugs Ther"},{"issue":"22","key":"10.1016\/j.amjmed.2018.05.022_bib0014","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2018.05.022_bib0015","unstructured":"National Heart, Lung, and Blood Institute. Systolic Blood Pressure Intervention Trial Primary Outcome Paper (SPRINT-POP) data. Available at: https:\/\/biolincc.nhlbi.nih.gov\/studies\/sprint_pop\/. Accessed January 28, 2017."},{"issue":"20","key":"10.1016\/j.amjmed.2018.05.022_bib0016","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2009.05.073","article-title":"The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?","volume":"54","author":"Messerli","year":"2009","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"10.1016\/j.amjmed.2018.05.022_bib0017","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1161\/HYPERTENSIONAHA.114.04581","article-title":"Does low diastolic blood pressure contribute to the risk of recurrent hypertensive cardiovascular disease events? The Framingham Heart Study","volume":"65","author":"Franklin","year":"2015","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.amjmed.2018.05.022_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004536","article-title":"Implications of blood pressure measurement technique for implementation of Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"6","author":"Agarwal","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"6658","key":"10.1016\/j.amjmed.2018.05.022_bib0019","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.297.6658.1227","article-title":"Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction","volume":"297","author":"Cruickshank","year":"1988","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.amjmed.2018.05.022_bib0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/08037051.2012.748998","article-title":"Albuminuria in relation to the single and combined effects of systolic and diastolic blood pressure in Chinese","volume":"22","author":"Sheng","year":"2013","journal-title":"Blood Press."},{"issue":"4","key":"10.1016\/j.amjmed.2018.05.022_bib0021","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S1474-4422(14)70018-3","article-title":"Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial","volume":"13","author":"Manning","year":"2014","journal-title":"Lancet Neurol"},{"issue":"24","key":"10.1016\/j.amjmed.2018.05.022_bib0022","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension","volume":"265","year":"1991","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.amjmed.2018.05.022_bib0023","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA."},{"issue":"5","key":"10.1016\/j.amjmed.2018.05.022_bib0024","first-page":"695","article-title":"Diastolic hypotension in a tertiary care hypertension clinic: have we gone too far?","volume":"32","author":"Mace-Brickman","year":"2016","journal-title":"Can J Cardiol."},{"issue":"8","key":"10.1016\/j.amjmed.2018.05.022_bib0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11883-017-0670-1","article-title":"The J-shaped curve for blood pressure and cardiovascular disease risk: historical context and recent updates","volume":"19","author":"Rahman","year":"2017","journal-title":"Curr Atheroscler Rep."},{"issue":"24","key":"10.1016\/j.amjmed.2018.05.022_bib0026","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.","volume":"265","year":"1991","journal-title":"JAMA."},{"key":"10.1016\/j.amjmed.2018.05.022_bib0027","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2017.07.019","article-title":"Diastolic hypotension due to intensive blood pressure therapy: is it harmful?","volume":"265","author":"Stensrud","year":"2017","journal-title":"Atherosclerosis."},{"issue":"2","key":"10.1016\/j.amjmed.2018.05.022_bib0028","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCULATIONAHA.117.030848","article-title":"Influence of baseline diastolic blood pressure on effects of intensive compared with standard blood pressure control","volume":"137","author":"Beddhu","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjmed.2018.05.022_bib0029","first-page":"589","article-title":"Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for blood pressure measurement, diagnosis, and assessment of risk of pediatric hypertension","volume":"32","author":"Harris","year":"2016","journal-title":"Can J Cardiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318305114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934318305114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:15:36Z","timestamp":1757582136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934318305114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0002934318305114"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.05.022","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}